| Literature DB >> 26071317 |
Kerry A McLaughlin1, Carolyn C Richardson1, Stefan Williams1, Ezio Bonifacio2, Diana Morgan3, Richard G Feltbower3, Michael Powell4, Bernard Rees Smith4, Jadwiga Furmaniak4, Michael R Christie5.
Abstract
Diversification of autoimmunity to islet autoantigens is critical for progression to Type 1 diabetes. B-cells participate in diversification by modifying antigen processing, thereby influencing which peptides are presented to T-cells. In Type 1 diabetes, JM antibodies are associated with T-cell responses to PTP domain peptides. We investigated whether this is the consequence of close structural alignment of JM and PTP domain determinants on IA-2. Fab fragments of IA-2 antibodies with epitopes mapped to the JM domain blocked IA-2 binding of antibodies that recognise epitopes in the IA-2 PTP domain. Peptides from both the JM and PTP domains were protected from degradation during proteolysis of JM antibody:IA-2 complexes and included those representing major T-cell determinants in Type 1 diabetes. The results demonstrate close structural relationships between JM and PTP domain epitopes on IA-2. Stabilisation of PTP domain peptides during proteolysis in JM-specific B-cells may explain determinant spreading in IA-2 autoimmunity.Entities:
Keywords: Autoantibody; Determinant spreading; Epitope; Monoclonal antibody; Type 1 diabetes
Mesh:
Substances:
Year: 2015 PMID: 26071317 DOI: 10.1016/j.clim.2015.06.002
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969